Moderator: Cynthia J. Girman, DrPH, FISPE (she/her/hers) – CERobs Consulting, LLC
### she/her/hers @@@ Chintan Dave, PharmD, PhD – Rutgers University ### 1655382###Moderator###Assistant Professor of Pharmacy and Epidemiology###Rutgers University###Moderator: Chintan Dave, PharmD, PhD – Rutgers University
###Presenting Author: Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and
### she/her/hers @@@ HoJin Shin, BPharm, PhD – Brigham and Women's Hospital ### 1062644### Co-Author###Postdoctoral Research Fellow###Brigham and Women's Hospital###Co-Author: HoJin Shin, BPharm, PhD – Brigham and Women's Hospital
### @@@ Julie M. Paik, MD, ScD – Brigham and Women's Hospital ### 1655332###Co-Author######Brigham and Women's Hospital###Co-Author: Julie M. Paik, MD, ScD – Brigham and Women's Hospital
### @@@ Brendan M. Everett, MD, MPH – Brigham and Women’s Hospital ### 1360564###Co-Author######Brigham and Women’s Hospital###Co-Author: Brendan M. Everett, MD, MPH – Brigham and Women’s Hospital
### @@@ Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital ### 1302713###Co-Author###Professor###Brigham and Women's Hospital###Co-Author: Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital
### @@@ Deborah J. Wexler, MD, MSc – Massachusetts General Hospital ### 1360566###Co-Author######Massachusetts General Hospital###Co-Author: Deborah J. Wexler, MD, MSc – Massachusetts General Hospital
###Presenting Author: Chase D. Latour (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Mark Klose – University of North Carolina at Chapel Hill ### 2325407###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Mark Klose – University of North Carolina at Chapel Hill
### @@@ Jessie Edwards, PhD MSPH – University of North Carolina at Chapel Hill ### 1358533###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Jessie Edwards, PhD MSPH – University of North Carolina at Chapel Hill
### @@@ Zoey Song, MPH – Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA ### 2325256###Co-Author######Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA###Co-Author: Zoey Song, MPH – Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
### @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Co-Author###Associate Professor###University of North Carolina at Chapel Hill###Co-Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Mollie E. Wood, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC ### 1659932###Co-Author###Assistant Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC###Co-Author: Mollie E. Wood, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
###Moderator: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### she/her/hers @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Moderator###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Moderator: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/hisPresenting Author: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Megan Wiley – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325529###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###Co-Author: Megan Wiley – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ David V. Cole – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325560###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###Co-Author: David V. Cole – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Inna Dashevsky – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325561###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###Co-Author: Inna Dashevsky – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Celeste LY Ewig, PharmD – University of Florida ### 1657495###Co-Author###Graduate Assistant###University of Florida###Co-Author: Celeste LY Ewig, PharmD – University of Florida
### @@@ Katherine Haffenreffer – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325563###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###Co-Author: Katherine Haffenreffer – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Earl J. Morris, IV, PharmD, MPH, PhD (he/him/his) – University of Florida ### 1063338###Co-Author###Research Assistant Professor###University of Florida###Co-Author: Earl J. Morris, IV, PharmD, MPH, PhD (he/him/his) – University of Florida
### he/him/his @@@ Elizabeth Siranosian – University of North Carolina ### 2325573###Co-Author######University of North Carolina###Co-Author: Elizabeth Siranosian – University of North Carolina
### @@@ Nicole E. E. Smolinski, PharmD – University of Florida ### 1358688###Co-Author###Graduate Student###University of Florida###Co-Author: Nicole E. E. Smolinski, PharmD – University of Florida
### @@@ Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325434###Co-Author###Research Scientist###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###Co-Author: Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy ### 1358834###Co-Author###Graduate Student###University of Florida, Department of Pharmaceutical Outcomes & Policy###Co-Author: Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy
### @@@ Yehua Wang, MSPH (he/him/his) – University of Florida, College of Pharmacy, Gainesville, FL, USA ### 1659868###Co-Author###Graduate Student###University of Florida, College of Pharmacy, Gainesville, FL, USA###Co-Author: Yehua Wang, MSPH (he/him/his) – University of Florida, College of Pharmacy, Gainesville, FL, USA
### he/him/his @@@ Audrey Wolfe – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325564###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###Co-Author: Audrey Wolfe – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Elizabeth A. Suarez, PhD – Rutgers Institute for Health ### 1991274###Co-Author###Instructor###Rutgers Institute for Health###Co-Author: Elizabeth A. Suarez, PhD – Rutgers Institute for Health
### @@@ Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc ### 2325147###Co-Author###Senior Research Scientist###Carelon Research, Inc###Co-Author: Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc
### she/her/hers @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health###Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health
### @@@ Margaret Adgent, MSPH, PhD – Department of Health Policy, Vanderbilt University Medical Center ### 1063010###Co-Author###Research Associate Professor###Department of Health Policy, Vanderbilt University Medical Center###Co-Author: Margaret Adgent, MSPH, PhD – Department of Health Policy, Vanderbilt University Medical Center
### @@@ Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine ### 1991648###Co-Author######Department of Genetic Medicine, Johns Hopkins School of Medicine###Co-Author: Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine
### @@@ Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###Co-Author: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hersPresenting Author: Janick Weberpals, RPh, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### he/him/his @@@ Pamela A. Shaw – Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA ### 1991182###Co-Author######Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA###Co-Author: Pamela A. Shaw – Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Joseph M. Plasek – Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325346###Co-Author######Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Joseph M. Plasek – Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Li Zhou – Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1658668###Co-Author######Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Li Zhou – Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325347###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Thomas DeRamus – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325348###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Thomas DeRamus – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Co-Author###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###Co-Author: Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers @@@ Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1991183###Co-Author###Associate Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###Co-Author: Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### he/him/his @@@ Hana Lee, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1655520###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Hana Lee, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325127###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###Co-Author: Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ John G. Connolly – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA ### 2325236###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA###Co-Author: John G. Connolly – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA
### @@@ Kimberly J. Dandreo – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA ### 2325349###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA###Co-Author: Kimberly J. Dandreo – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA
### @@@ Fang Tian – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1659617###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Fang Tian – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration ### 1358274###Co-Author######Office of Surveillance and Epidemiology, US Food and Drug Administration###Co-Author: Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration
### @@@ Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA ### 1062564###Co-Author###Associate Director RWE###Office of Surveillance and Epidemiology, CDER, US FDA###Co-Author: Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA
### she/her/hers @@@ José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1991185###Co-Author###Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###Co-Author: José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
###Presenting Author: Michael J. Munsell, PhD – Panalgo
### @@@ Mark Friedman, MD – Panalgo ### 1358265###Co-Author######Panalgo###Co-Author: Mark Friedman, MD – Panalgo
### @@@ Joseph Menzin, PhD – Panalgo ### 1063316###Co-Author######Panalgo###Co-Author: Joseph Menzin, PhD – Panalgo
### @@@ Tiffany S. Siu Woodworth, MPH, MBA – Panalgo ### 1062696###Co-Author######Panalgo###Co-Author: Tiffany S. Siu Woodworth, MPH, MBA – Panalgo
###Speaker: Alejandro Arana – RTI Health Solutions
### @@@ Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062544###Speaker###Professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Speaker: Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Yuchen Guo, PhD – University of Oxford ### 1360088###Speaker###Postdoctoral researcher###University of Oxford###Speaker: Yuchen Guo, PhD – University of Oxford
### @@@ Patrick B. Ryan, PhD – Johnson and Johnson Innovative Medicine ### 1661016###Speaker######Johnson and Johnson Innovative Medicine###Speaker: Patrick B. Ryan, PhD – Johnson and Johnson Innovative Medicine
### @@@ Andrea V. Margulis, MD, ScD, FISPE – RTI Health Solutions, Barcelona, Spain ### 1046827###Moderator###Senior Director###RTI Health Solutions, Barcelona, Spain###Moderator: Andrea V. Margulis, MD, ScD, FISPE – RTI Health Solutions, Barcelona, Spain
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Moderator###Professor of Pharmaco-and Device Epidemiology###University of Oxford###Moderator: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/hisLead Speaker: Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands
### @@@ Chloé Corrie Hans Smit, PharmD – University of Technology Sydney ### 1658456###Speaker###PhD researcher###University of Technology Sydney###Speaker: Chloé Corrie Hans Smit, PharmD – University of Technology Sydney
### @@@ Maarten Lambert, MA (he/him/his) – University of Groningen ### 1657490###Speaker###PhD Candidate###University of Groningen###Speaker: Maarten Lambert, MA (he/him/his) – University of Groningen
### he/him/his @@@ Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University ### 1093644###Speaker###Associate professor###Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University###Speaker: Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University
### she/her/hers @@@ Luciane Cruz Lopes, ScD, MSc – Pharmaceutical Science Graduate Course. University of Sorocaba, Sao Paulo, Brazil ### 1659927###Speaker###Full professor and senior researcher###Pharmaceutical Science Graduate Course. University of Sorocaba, Sao Paulo, Brazil###Speaker: Luciane Cruz Lopes, ScD, MSc – Pharmaceutical Science Graduate Course. University of Sorocaba, Sao Paulo, Brazil
### @@@ Ria Benkő, Dr. (she/her/hers) – Institute of Clinical Pharmacy, University of Szeged ### 1993178###Speaker###Associate Professor###Institute of Clinical Pharmacy, University of Szeged###Speaker: Ria Benkő, Dr. (she/her/hers) – Institute of Clinical Pharmacy, University of Szeged
### she/her/hers @@@ Lisa G. Pont, PhD, FISPE – University of Technology Sydney ### 1655255###Speaker###Professor of Pharmacy###University of Technology Sydney###Speaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney
###Lead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE (she/her/hers) – IQVIA
### she/her/hers @@@ Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc. ### 1088313###Speaker###Executive Director of Observational Research###Amgen, Inc.###Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
### she/her/hers @@@ Thijs J. Giezen, PhD – Spaarne Gasthuis ### 1088311###Speaker###Hospital Pharmacist###Spaarne Gasthuis###Speaker: Thijs J. Giezen, PhD – Spaarne Gasthuis
### @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Speaker###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
###Presenting Author: Martin Torp Rahbek, MD (he/him/his) – University of Southern Denmark
### he/him/his @@@ Søren Andreas Just – Odense University Hospital ### 2325198###Co-Author######Odense University Hospital###Co-Author: Søren Andreas Just – Odense University Hospital
### @@@ Kasper Bruun Kristensen – Odense University Hospital ### 2325199###Co-Author######Odense University Hospital###Co-Author: Kasper Bruun Kristensen – Odense University Hospital
### @@@ Hussam Mahmoud Sheta – University of Southern Denmark ### 2325200###Co-Author######University of Southern Denmark###Co-Author: Hussam Mahmoud Sheta – University of Southern Denmark
### @@@ Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark ### 1062967###Co-Author###Professor of clinical pharmacology###University of Southern Denmark###Co-Author: Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark
### he/him/his @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Co-Author###Professor###University of Southern Denmark###Co-Author: Anton Pottegård, PhD, DMSc – University of Southern Denmark
### @@@ Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 1062545###Co-Author###Postdoctoral researcher###Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###Co-Author: Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### he/him/hisPresenting Author: Euloge Clovis Kenne Pagui, PhD – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Norway
### @@@ Simon Boge Brant – NordicRWE AS, Oslo, Norway ### 2325243###Co-Author###Statistitian###NordicRWE AS, Oslo, Norway###Co-Author: Simon Boge Brant – NordicRWE AS, Oslo, Norway
### @@@ Kristian Svendsen, PhD – NordicRWE AS, Oslo, Norway ### 2325244###Co-Author###Associate professor in pharmacoepidemiology###NordicRWE AS, Oslo, Norway###Co-Author: Kristian Svendsen, PhD – NordicRWE AS, Oslo, Norway
### @@@ Arnoldo Frigessi – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo ### 2325245###Co-Author###Full professor###1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo###Co-Author: Arnoldo Frigessi – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo
### @@@ Åslaug Helland – Division of Cancer Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo ### 2325246###Co-Author###Professor, group leader###Division of Cancer Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo###Co-Author: Åslaug Helland – Division of Cancer Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo
### @@@ Steinar Ø Thoresen, MD PhD Professor emeritus – NordicRWE AS, Oslo, Norway ### 2325247###Co-Author###Medical Director###NordicRWE AS, Oslo, Norway###Co-Author: Steinar Ø Thoresen, MD PhD Professor emeritus – NordicRWE AS, Oslo, Norway
### @@@ Christian Jonasson – Norwegian University of Science and Technology ### 1655995###Co-Author######Norwegian University of Science and Technology###Co-Author: Christian Jonasson – Norwegian University of Science and Technology
###